House
GuidelinesCalculatorsPricingBlog
Ask House ↗
Guidelines↗Calculators↗Pricing↗Blog↗
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House
Back to guidelines
Obstetrics & gynaecology

Twin and triplet pregnancy

NICE · 2024 edition / updateSource checked 29 October 2026
Read the source publication
House clinical summary

Scope

NICE NG137 organizes twin and triplet care by chorionicity and amnionicity, because shared placental and amniotic structures determine surveillance and delivery risks. Its selected recommendations include the updated short-cervix progesterone pathway, fetal-growth and transfusion surveillance, and pregnancy-specific timing and mode of birth.

Written by House with AI assistance · AI-assisted source check 29 October 2026.

This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.

Establish the pregnancy type and specialist plan

  • Offer first-trimester ultrasound to date pregnancy and determine chorionicity and amnionicity. Date from the largest baby to avoid early growth pathology distorting the estimate, and use consistent labels for each baby throughout care. [1]
  • If chorionicity or amnionicity is uncertain, obtain expert ultrasound review promptly. If chorionicity remains uncertain after referral, manage as monochorionic until proved otherwise. Shared-amnion pregnancies require individualized tertiary fetal-medicine care. [1]
  • Use a named specialist obstetric, midwifery and sonography team. Offer psychological, nutrition, feeding or physiotherapy support according to individual need; extra-team referral is not automatic for every multiple pregnancy. [1]
  • Anticipate increased anaemia risk. In addition to booking blood tests, obtain a full blood count at 20–24 weeks to identify early iron or folate supplementation needs and repeat at 28 weeks. [1]

Separate growth and shared-placenta surveillance

  • For dichorionic twins or trichorionic triplets, assess fetal-weight discordance and amniotic fluid by ultrasound from 24 weeks. Subsequent intervals must not exceed 28 days for dichorionic twins or 14 days for trichorionic triplets. [1]
  • For monochorionic twins or triplets, monitor simultaneously for fetal transfusion, growth restriction and advanced TAPS. Begin transfusion and growth ultrasound monitoring at 16 weeks, with intervals no longer than 14 days. [1]
  • In monitored twin or triplet pregnancy, escalate to at least weekly surveillance with umbilical-artery Doppler for each baby if estimated fetal-weight discordance is ≥20% and/or any estimated weight is below the 10th gestational-age centile. [1]
  • Refer to tertiary fetal medicine for selective growth-restriction concern when estimated fetal-weight discordance is ≥25% AND any baby’s estimated weight is below the 10th gestational-age centile. Both criteria distinguish this referral trigger from the broader intensified-surveillance trigger. [1]
  • For monochorionic pregnancies, increase transfusion surveillance to at least weekly with each baby’s umbilical Doppler when deepest vertical fluid pockets differ by ≥4 cm. Refer for diagnosed transfusion syndrome when one pocket is <2 cm AND another is >8 cm before 20+0 weeks or >10 cm from 20+0 weeks. [1]
  • Offer weekly MCA peak-systolic-velocity monitoring for TAPS from 16 weeks after fetoscopic laser treatment of transfusion syndrome, or with selective growth restriction defined by ≥25% weight discordance AND a baby below the 10th centile. [1]

Prevent preterm birth and screen maternal complications

  • Offer a single cervical-length scan at 16–20 weeks. For a twin or triplet pregnancy with cervical length ≤25 mm, offer vaginal progesterone 200 mg at bedtime daily until 34 weeks or earlier birth. [1]
  • Also offer vaginal progesterone 200 mg nightly until 34 weeks or earlier birth if a cervix ≤25 mm is incidentally found on a scan at 20–24 weeks. The source identified this formulation’s use as off-label when updated. [1]
  • Do not offer intramuscular progesterone for spontaneous preterm-birth prevention. Do not routinely offer pessary, bed rest, cerclage or oral tocolytics for this prevention indication in twin or triplet pregnancies. [1]
  • Discuss targeted antenatal corticosteroids when preterm birth risk warrants them; do not give untargeted routine single or repeated courses solely because pregnancy is multiple. Check blood pressure and urine protein at every antenatal appointment. [1]

Plan timing and mode for the specific pregnancy

  • Begin birth-planning discussions from 24 weeks and address location, timing, mode, analgesia, monitoring and third-stage care by 28 weeks. Explain that preterm birth can require neonatal-unit admission. [1]
  • For uncomplicated dichorionic diamniotic twins, offer planned birth at 37 weeks. For uncomplicated monochorionic diamniotic twins, offer at 36 weeks after considering antenatal corticosteroids. [1]
  • After considering antenatal corticosteroids, offer planned birth at 32+0–33+6 weeks for uncomplicated monochorionic monoamniotic twins and at 35 weeks for uncomplicated trichorionic or dichorionic triamniotic triplets. [1]
  • Individualize planned-birth timing for any complicated multiple pregnancy, monochorionic triamniotic triplets or triplets sharing an amnion. If recommended planned birth is declined, offer weekly specialist review, fluid and umbilical Doppler assessments, plus fortnightly growth scans. [1]
  • For uncomplicated diamniotic twins beyond 32 weeks, vaginal or caesarean birth are both safe choices only when there is no labour contraindication, the first twin is cephalic and there is no significant size discordance. [1]
  • Offer caesarean birth if the first twin is non-cephalic at planned birth or in established preterm labour at 26–32 weeks. Before 26 weeks, assess mode individually with survival chances and maternal surgical risk. [1]
  • Offer caesarean birth for monoamniotic twins at planned birth and for triplet pregnancies at planned birth. Earlier complications or preterm labour require the source’s gestation- and survival-specific assessment, rather than waiting for the routine date. [1]

Monitor both babies and prepare for bleeding

  • In established twin labour beyond 26 weeks, offer continuous dual-channel CTG. Use ultrasound to confirm fetal identity and presentation; label each trace, monitor maternal pulse and check that the same baby is not recorded twice. [1]
  • Offer epidural analgesia for a planned vaginal multiple birth and regional anaesthesia for caesarean birth. Explain that an epidural can facilitate assisted birth or a quicker emergency caesarean when necessary. [1]
  • Offer active rather than physiological third-stage management for twin or triplet birth. Assess haemorrhage risk, consider additional uterotonics when other risk factors exist, and ensure intravenous access, full blood count and group-and-save at established labour. [1]

Limitations and use

  • This is a selected clinical pathway rather than every appointment schedule, fetal intervention, intrapartum escalation rule or medicine protocol. Complicated pregnancies and shared amnions require specialist individualized care. The aspirin risk-factor list, complete targeted corticosteroid criteria and treatment of fetal transfusion syndromes must be consulted separately; they are not established by this summary.

This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.

Summary sources

  1. 1
    Twin and triplet pregnancy

    Selected recommendation material consulted

Original guideline

Publication details

Issuing organisation
NICE
First published
4 September 2019
Publisher’s latest update
9 April 2024
Resource type
Clinical guideline · House clinical summary

The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.

On this page

  • Scope
  • Establish the pregnancy type and specialist plan
  • Separate growth and shared-placenta surveillance
  • Prevent preterm birth and screen maternal complications
  • Plan timing and mode for the specific pregnancy
  • Monitor both babies and prepare for bleeding
  • Limitations and use
  • Summary sources
  • Publication details
House
Clinical AIRoundsGuidelinesCalculatorsPricingBlogAboutEditorial policyPrivacyTermsLog in ↗
Clinical intelligence, for physicians.© 2026 House